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Background
HPV infection is considered the most frequent sexually
transmitted infection. The clinical manifestations of
infection are various and variable, including the ones in
ENT, such as recurrent laryngeal papillomatosis and
tonsillar cancer.
Case report
We present the possibilities of diagnosis of HPV infection
in ENT, and the therapeutic, prophylactic and curative
modalities, as well as the assumptions and prevention
goals through vaccination within this specialty. We com-
municate the management of three clinical cases of laryn-
geal papillomatosis in adults.
The first case, a 75-year-old woman, 4 times under sur-
gical intervention with “cold surgery”, vaccinated with
Silgard. The second case, a 55-year-old woman, also 4
times under surgical intervention receives Gardasil after
the last intervention. The third case, a 35-year-old man, 2
times surgically operated after diagnosed with papiloma
scuamosis and vaccined with Silgard.
All the above mentioned cases don’t present any
regression of the disease during the last three years.
Conclusion
The involvement of HPV in ENT cancer pathology is
undeniable. Laryngeal papillomatosis is a precancerous
condition caused by HPV strains 6 and 11. HPV vaccina-
tion can be useful both to prevent HPV-induced pathology
in otolaryngology and after surgery, to prevent recurrence.
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